PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices

Procurement notices · Find a Tender + Contracts Finder

Notices

Every UK public-sector procurement notice in one board — open opportunities, closed tenders, awards, and pre-market signals. Filter by deadline, value or CPV, and save your search as an alert.

FiltersReset all
Quick views
  • All open noticesLive opportunities
  • Closing today / tomorrow
  • Closing this week
  • Newly published (24h)
  • High value (£10m+)
  • Awards · last 7 daysMarket signal
  • Pre-market signalsFuture procurements
  • Recently closedAwaiting outcome
  • All noticesEvery PA23 type
Type
  • All
  • Services
  • Supplies
  • Works
Value
  • Any
  • £100k+
  • £1m+
  • £10m+
  • £100m+
Published
  • Any
  • Last 24 hours
  • Last 7 days
  • Last 30 days
Category
  • All categories
  • IT services
  • Software packages
  • Business services
  • Health & social
  • Construction work
  • Medical equipment
  • Architecture & engineering
  • Repair & maintenance
  • Financial services
  • Education & training
ActiveView: All notices×Clear all
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
Closing 24h
4
Open notices
Closing this week
5
Don’t miss
Open · all
70,824
Live opportunities
Posted · 24h
201
New notices
Posted · 30d
6,532
All notice types
Awarded · 7d
852
Market signal

Notice peek

×
BC
AwardFTS · 0585e0

BCU-FTS-59576 CELLULAR PATHOLOGY REAGENT DELIVERY AND COLLECTION

Betsi Cadwaladr University Health Board
Status
complete
Estimated
—
Published
25 Jun 2026

Key facts

Notice ID
ocds-h6vhtk-0585e0
Awarded to
CellPath Limited
Source
Find a Tender

Timeline

  1. Published
    25 Jun 2026
  2. Awarded
    25 Jun 2026

Description

Betsi Cadwaladr University Health Board (BCUHB) Cellular Pathology routinely uses substantial volumes of Formalin, Xylene, and other specialised reagents in the histological preparation and analysis of tissue specimens. These reagents are critical in investigating a broad spectrum of conditions, including malignant and benign tumours, as well as other tissue and cellular abnormalities, to enable accurate diagnosis and guide targeted treatment pathways. BCUHB seeks to appoint a suitably qualified supplier capable of delivering a reliable and timely supply of these reagents, alongside a dedicated service for the safe collection and compliant disposal of associated chemical waste. This will ensure uninterrupted laboratory operations, full regulatory compliance, and continuity of service.

You might also see

  • All Betsi Cadwaladr University Health Board notices →
Open full notice ↗View in this tab
0 noticesall types · sorted by publication date
Page 147
Time to close
Value
Type
Buyer
Notice
This view is too broad — add a filter (category, value or search term) and try again.